Thank you very much, Adanna, and good afternoon, everyone. Cytosorbents Corporation continues to make solid progress as we ...
Before proceeding, let me mention that any forward-looking statements included in the presentation or mentioned in this ...
Building a social media brand has helped enrich players. But constant harassment — fueled in part by sports gambling — has ...
Clinical Outcomes -- Twelve-month study data for the Catamaran implant showed VAS scores decreased from 78.8 to 23, and ODI ...
Guidance Raised -- 2025 revenue target increased to $80.5 million–$81.5 million, midpoint 38.7% growth; net income projected ...
Even the smallest updates can be massive time savers. Here’s what HubSpot tackled in October. The post October 2025 HubSpot updates include faster files, cleaner data and smarter AI appeared first on ...
Operator: Good afternoon, ladies and gentlemen, and welcome to the CytoSorbents Corp. Third Quarter 2025 Earnings Conference ...
The shooting marks the second time in the past month that a Homeland Security agent has shot at a car while patrolling with D ...
Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.30404 EPS, expectations were $-0.04. Operator ...
Gap is on watch on Friday after Jefferies turned bullish on the retailer. The firm believes that new leadership at Gap has ...
Trump mentions a potential change to the Affordable Care Act that would replace subsidies with a personal account to choose a ...
Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results